-
Rossari to acquire Tristar Intermediates
expresspharma
July 23, 2021
Rossari will be acquiring 100 per cent of the equity share capital of Tristar Intermediates.
-
AstraZeneca Completes Acquisition of Alexion
americanpharmaceuticalreview
July 22, 2021
AstraZeneca completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca.
-
Philip Morris agrees to acquire Vectura for $1.45bn
pharmaceutical-technology
July 13, 2021
Philip Morris International (PMI) has made an offer to acquire a contract development and manufacturing organisation (CDMO), Vectura Group, for approximately $1.45bn (£1.045bn) to boost its product pipeline development expertise in inhaled treatments.
-
AstraZeneca receives EC approval for $39bn Alexion acquisition
pharmaceutical-technology
July 07, 2021
The European Commission has cleared the proposed acquisition by AstraZeneca of US-based biopharmaceutical company Alexion Pharmaceuticals for approximately $39bn or $175 a share.
-
Philip Morris to acquire Fertin Pharma for $812.8m
pharmaceutical-business-review
July 02, 2021
Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn).
-
Piramal Pharma completes acquisition of Hemmo Pharmaceuticals
expresspharma
June 24, 2021
Piramal Pharma has completed the acquisition of Hemmo Pharmaceuticals, according to a statement released by the company.
-
Danaher To Acquire Aldevron for $9.6B
contractpharma
June 22, 2021
Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
-
Solvias Acquires Chemic Labs
contractpharma
June 21, 2021
Solvias, an analytical testing, contract research, development and manufacturing company, has acquired Chemic Laboratories, Inc. based in Canton, MA.
-
Premier Research Acquires Camargo Pharmaceutical Services
contractpharma
May 24, 2021
Premier Research has acquired Camargo Pharmaceutical Services based in Cincinnati, OH.
-
CD&R to acquire UDG Healthcare for $3.7bn
pharmaceutical-technology
May 14, 2021
Private equity firm Clayton, Dubilier & Rice (CD&R) has agreed to acquire Ireland-based UDG Healthcare for a total of $3.7bn (£2.6bn) in cash.